Humacyte, Inc. HUMA
NASDAQ · United States · Health Technology
$0.5215+0.02 (+3.70%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.16 | -0.11 | -41.0% | $406.00K | -61.0% | -22.5%$0.71→$0.55 |
| Q1 2026 | 2026-05-13 | -0.09 | -0.11 | +18.2% | — | — | +9.9%$0.91→$1.00 |
| Q4 2025 | 2026-03-27 | -0.13 | -0.13 | 0.0% | — | — | -26.1%$0.78→$0.57 |
| Q3 2025 | 2025-11-12 | -0.11 | -0.15 | +26.7% | — | — | -7.0%$1.28→$1.19 |
| Q2 2025 | 2025-08-11 | -0.24 | -0.18 | -33.3% | — | — | — |
| Q1 2025 | 2025-05-13 | 0.28 | -0.19 | +247.4% | — | — | — |
| Q4 2024 | 2025-03-28 | -0.21 | -0.25 | +16.0% | — | — | — |
| Q3 2024 | 2024-11-08 | -0.26 | -0.24 | -8.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.